XML 58 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Investments (Tables)
12 Months Ended
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments and Investments Carried Under Measurement Alternative
Equity Method Investments and Investments Carried Under the Measurement Alternative
(in thousands)
Percent Ownership1
December 31, 2022December 31, 2021
Advanced Markets Holdings25%$5,090 $5,110 
China Credit BGC Money Broking Company Limited33%21,104 16,784 
Freedom International Brokerage45%9,659 9,794 
Other2,530 1,159 
Equity method investments$38,383 $32,847 
Investments carried under measurement alternative192 192 
Total equity method and investments carried under measurement alternative$38,575 $33,039 
_______________________________________
1Represents the Company’s voting interest in the equity method investment as of December 31, 2022 and 2021.
Summary of Financial Information for Company's Equity Method Investments
Summarized financial information for the Company’s equity method investments is as follows (in thousands):
Year Ended December 31,
202220212020
Statements of operations:
Total revenues$125,405 $108,458 $94,744 
Total expenses88,050 82,581 71,241 
   Income before income taxes$37,355 $25,877 $23,503 
December 31,
20222021
Statements of financial condition:
Cash and cash equivalents$82,725 $104,855 
Fixed assets, net1,848 2,603 
Other assets54,744 42,640 
Total assets$139,317 $150,098 
Payables to related parties— 2,000 
Other liabilities78,740 92,114 
Total partners’ capital60,577 55,984 
Total liabilities and partners’ capital$139,317 $150,098 
Investments in Variable Interest Entities
The following table sets forth the Company’s investment in its unconsolidated VIEs and the maximum exposure to loss with respect to such entities (in thousands).
December 31, 2022December 31, 2021
InvestmentMaximum
Exposure to Loss
InvestmentMaximum
Exposure to Loss
Variable interest entities1
$2,530 $2,959 $1,159 $2,139 
__________________
1The Company has entered into a subordinated loan agreement with Aqua, whereby the Company agreed to lend the principal sum of $980 thousand. The Company’s maximum exposure to loss with respect to its unconsolidated VIEs includes the sum of its equity investments in its unconsolidated VIEs and the $430 thousand and $980 thousand subordinated loan to Aqua as of December 31, 2022 and 2021, respectively. The Company did not recognize any interest income on the subordinated loan subsequent to being designated as a non-accrual loan in November 2022. As of December 31, 2022, the Company wrote off $550 thousand of the subordinated loan, which was recorded as part of "Other expenses" on the Company's Consolidated Statements of Operations.